BackOncology Institute(The) Overview
Oncology Institute Inc (The)

Oncology Institute(The) Target Price

Analysts' average 12-month price target for Oncology Institute(The) is $8.5.

Get informed when a big investor buys or sells

+ Follow

Share Price

$5.13

Average Target Price

$8.5065.7% upside

4 analysts in the last 4 months

High: $10 | Low: $7

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-07-09BTIG$975.4% upsideOpen
2026-07-06Lake Street$1094.9% upsideOpen
2026-06-17Needham$736.5% upsideOpen
2026-06-08BTIGDavid Larsen$855.9% upsideOpen
2025-11-25NeedhamMatthew Shea$52.5% downsideOpen
2022-11-11Guggenheim$617% upsideOpen
2022-08-15Jefferies$1094.9% upsideOpen

Oncology Institute(The) (TOI) FAQ

Oncology Institute(The) posts a target price of $8.5. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

A target price of $8.5 for TOI means covering analysts, on average, see the stock 65.7% upside of $5.13 over about 12 months. Dig into who set the high and low targets and how recently they updated — freshness matters as much as the average itself.

Context for TOI's target price usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Oncology Institute(The)'s other metric pages and overview cover the third.